Sona Nanotech Inc. announced the filing of a U.S. provisional patent application regarding a gold nanorod conjugation concept for targeted drug delivery and deployment applications in the medical field. The Company intends to convert the filing to an international patent application and/or regular patent applications in various countries, including the U.S., over the next year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 CAD | -8.77% | -16.13% | +8.33% |
05-21 | Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent | MT |
05-21 | Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio Md, Msc., Frcsc as Chief Medical Officer | CI |
1st Jan change | Capi. | |
---|---|---|
+8.33% | 20.7M | |
-4.16% | 183B | |
-2.39% | 104B | |
-4.08% | 68.18B | |
+16.04% | 47.14B | |
-11.10% | 43.97B | |
+8.28% | 40.95B | |
+17.63% | 31.05B | |
-8.10% | 24.11B | |
+13.87% | 24.05B |
- Stock Market
- Equities
- SONA Stock
- News Sona Nanotech Inc.
- Sona Nanotech Inc. Files Provisional Conjugation Patent